Marshall Wace’s Array Biopharma Inc ARRY Stock Holding History

Marshall Wace’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-162,861	Closed	-$7.54M	–	2039
2019 Q2	$7.54M	Buy	162,861 +42,116	+35%	+$1.18M	0.06%	362
2019 Q1	$2.94M	Sell	120,745 -44,559	-27%	-$928K	0.03%	637
2018 Q4	$2.35M	Buy	+165,304	New	+$2.51M	0.02%	690
2016 Q4	–	Sell	-11,129	Closed	-$75K	–	1201
2016 Q3	$75K	Buy	+11,129	New	+$43K	﹤0.01%	911
2014 Q3	–	Sell	-156,908	Closed	-$716K	–	1121
2014 Q2	$716K	Buy	+156,908	New	+$649K	0.01%	556

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Marshall Wace's ARRY Position: Q3 2019 in Review

Marshall Wace sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 162,861 shares — an estimated $7.54M sold.

Marshall Wace first reported a position in ARRY in Q2 2014 and held it in 5 quarters. The position peaked at $7.54M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Marshall Wace reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Marshall Wace sold 162,861 Array Biopharma Inc shares in Q3 2019, an estimated $7.54M.
Marshall Wace first reported a position in Array Biopharma Inc in Q2 2014 and held it in 5 quarters.
Marshall Wace's Array Biopharma Inc position peaked at $7.54M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Marshall Wace's 13F filing for Q3 2019, filed 14 Nov 2019.